Cencora, Inc. announced that it has entered into a definitive agreement to acquire the majority of OneOncology’s equity interests that it does not already own. OneOncology is a physician-led national platform that supports independent oncology practices, and the acquisition comes from TPG, a global alternative asset management firm.
Health Technology Insights: AI Governance in Drug Safety: Lessons from IQVIA
Bob Mauch, President and CEO of Cencora, said that accelerating the acquisition aligns with the company’s pharmaceutical-focused strategy and expands its management services capabilities. He noted that OneOncology has grown significantly since Cencora’s initial investment, attracting leading practices and physicians while enhancing patient access to high-quality care in local communities. Mauch added that combining OneOncology with Cencora’s recent acquisition of Retina Consultants of America will strengthen research and clinical trial capabilities, expand technology resources, and leverage physician leadership to create additional value for stakeholders.
Health Technology Insights: University of Rochester Medical Center and GE HealthCare Launch 7-Year Care Alliance
Jeff Patton, M.D., CEO of OneOncology, highlighted that advancing the partnership with Cencora will allow independent providers to benefit from Cencora’s expertise while maintaining their autonomy. He explained that as cancer care becomes increasingly complex, the collaboration will enhance the ability of physicians to deliver innovative and accessible treatments to patients.
The acquisition supports Cencora’s pharmaceutical-centric strategy and is expected to advance three key growth priorities. First, it strengthens Cencora’s specialty solutions by offering tools that streamline physician operations, support advanced treatments, and enable more patient engagement. Second, it positions the company alongside market leaders, as OneOncology has consistently attracted top physicians and built a network that shapes best practices in community-based care. Finally, it enhances patient access to medications by simplifying care navigation, accelerating clinical trial enrollment, and providing cost-effective access to innovative therapies. The combination of Cencora, OneOncology, and Retina Consultants of America is designed to leverage their collective strengths, drive innovation, and improve patient outcomes across community oncology practices.
Health Technology Insights: GE HealthCare Launches Imaging 360 Powered By AI to Improve Operations Efficiency
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
